Related Experiment Video

Updated: May 22, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

Pharmacology in the very young: anaesthetic implications

Brian J Anderson1

  • 1Department of Anaesthesiology, University of Auckland, Auckland, New Zealand. briana@adhb.govt.nz

European Journal of Anaesthesiology
|May 1, 2012
PubMed

Insights

Infant anesthesia dosing requires careful pharmacokinetic and pharmacodynamic evaluation due to rapid developmental changes. Understanding these factors is crucial for safe and effective pediatric anesthesia, especially in neonates and infants.

Area of Science:

  • Pediatric Anesthesiology
  • Developmental Pharmacology
  • Pharmacokinetics and Pharmacodynamics

Background:

  • Infant anesthesia dosing differs significantly from adults due to distinct disease processes and physiological maturation.
  • Rapid changes in absorption, distribution, and clearance occur during infancy due to anatomical, physiological, and behavioral development.
  • Pharmacogenomic expression also undergoes maturation in this critical developmental period.

Purpose of the Study:

  • To highlight the importance of pharmacokinetic-pharmacodynamic (PK-PD) considerations for anesthesia dosing in infants (0-2 years).
  • To emphasize the distinct physiological and developmental factors influencing drug disposition and response in this age group.
  • To identify the need for improved clinical tools for assessing pharmacodynamic feedback in pediatric anesthesia.

Main Methods:

  • Review of developmental pharmacology principles relevant to infant anesthesia.
  • Discussion of pharmacokinetic modeling approaches (population-based and physiologically-based) for dose approximation.
  • Analysis of current limitations in pharmacodynamic monitoring for anesthesia depth, sedation, and pain in infants.

Main Results:

  • Postmenstrual age is a more accurate indicator of maturation than postnatal age for anesthesia dosing.
  • Pharmacokinetic modeling has enhanced understanding of infant maturation and dose adjustments.
  • Effective pharmacodynamic monitoring tools exist for neuromuscular blockade but are lacking for anesthesia depth, sedation, and pain.

Conclusions:

  • Anesthesia dosing in infants necessitates a deep understanding of developmental pharmacology and PK-PD principles.
  • Historical high morbidity and mortality in this age group are partly due to insufficient grasp of developmental pharmacology.
  • Further development of clinically applicable pharmacodynamic assessment tools is essential for improving pediatric anesthesia safety.

More Related Videos

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...